Blogs

Choose from a variety of resources to get a better understanding of Syngene’s point of view, expertise or approach to drug discovery, development and manufacturing to ensure client success.

Integrated Drug Discovery: why expertise matters
See how chemistry, biology, DMPK, and DMTA expertise with a trusted preclinical CRO make integrated drug discovery faster and more reliable. Read now.
18th Dec, 2025
Bispecific antibodies: engineering complexity into simplicity
Clear guidance on bispecific antibodies, from formats and engineering to analytics and control strategy, for scalable development and manufacturing. Read now.
15th Dec, 2025
Integrated Expertise for Complex Modalities: Driving Innovation in Molecular Glue Discovery
Prove induced proximity in molecular glues with ITC, fluorescence polarization, and co-IP. Practical steps for stronger discovery decisions. Read the guide.
15th Dec, 2025
Plasmid, mRNA, & Viral Vector Manufacturing: Scaling for the Gene Therapy Boom
Explore how plasmid DNA, mRNA CDMO, and viral vector manufacturing are scaling to meet the rising demand of AAV gene therapy and genetic medicines. Read on to know more.
1st Dec, 2025
Beyond timelines: How Syngene redefines customer-centric project management
Customer-centric pharma project management software for CRDMO programs—integrating metrics, feedback, and risk on one platform to deliver with speed and quality.
26th Nov, 2025
Translational Research at Syngene: From Discovery to Personalized Medicine
Syngene’s translational research speeds drug discovery and development and enables personalized medicine with robust models and biomarkers. Explore the approach.
26th Nov, 2025
Batch Manufacturing vs Continuous Manufacturing with Process Analytical Technology
Batch vs continuous manufacturing explained, how process analytical technology enables control and real-time release testing, and when each mode fits best.
13th Nov, 2025
The Critical Role of Analytical Development: Supporting a Program with 70+ Method Validations
See how analytical development scales to 70 plus method validations with phase appropriate, risk based strategy and clean execution. Read the full guide today.
6th Nov, 2025
Urban Mental Health: Evidence, Action, and Impact through BUMHI
Explore how the BUMHI initiative advances urban mental health through research, evidence-based action, and community impact to build healthier cities.
5th Nov, 2025
Cost of Goods Reduction by Design: Strategies for Early-Phase Process Optimization
Reduce CoG by using design of experiments, quality by design, and smart tech transfer in early development. Practical strategies to cut cost without risk.
31st Oct, 2025

To view or email, Please share your details view

Your browser does not support this function.

To download, Please share your details

To view or email, Please share your details view

To download, Please share your details